Anzahl der Einträge: 4.
Liu, Xianqiong,
Hu, Junjie,
Song, Xinhua,
Utpatel, Kirsten,
Evert, Matthias und
Calvisi, Diego F.
(2019)
Combined treatment with MEK and mTOR inhibitors is effective in vitro and in vivo models of hepatocellular carcinoma.
Cancers 11, S. 930.
Zhang, Shanshan,
Song, Xinhua,
Cao, Dan,
Xu, Zhong,
Fan, Biao,
Che, Li,
Hu, Junjie,
Chen, Bin,
Dong, Mingjie,
Pilo, Maria G.,
Cigliano, Antonio ,
Evert, Katja,
Ribback, Silvia,
Dombrowski, Frank,
Pascale, Rosa M.,
Cossu, Antonio,
Vidili, Gianpaolo,
Porcu, Alberto,
Simile, Maria M.,
Pes, Giovanni M.,
Giannelli, Gianluigi,
Gordan, John,
Wei, Lixin,
Evert, Matthias,
Cong, Wenming,
Calvisi, Diego F. und
Chen, Xin
(2017)
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice.
Journal of Hepatology 67 (6), S. 1194-1203.
Volltext nicht vorhanden.
Wang, Chunmei,
Che, Li,
Hu, Junjie,
Zhang, Shanshan,
Jiang, Lijie,
Latte, Gavinella ,
Demartis, Maria I.,
Tao, Junyan,
Gui, Bing,
Pilo, Maria G.,
Ribback, Silvia,
Dombrowski, Frank,
Evert, Matthias,
Calvisi, Diego F. und
Chen, Xin
(2016)
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade.
Liver International 36 (8), S. 1176-1186.
Volltext nicht vorhanden.
Hu, Junjie,
Che, Li,
Li, Lei,
Pilo, Maria G.,
Cigliano, Antonio ,
Ribback, Silvia,
Li, Xiaolei,
Latte, Gavinella ,
Mela, Marta,
Evert, Matthias,
Dombrowski, Frank,
Zheng, Guohua,
Chen, Xin und
Calvisi, Diego F.
(2016)
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
Scientific Reports 6 (1).
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Tue May 7 16:12:10 2024 CEST.